Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo

Marie Violet, Alban Chauderlier, Lucie Delattre, Meryem Tardivel, Meliza Sendid Chouala, Audrey Sultan, Elodie Marciniak, Sandrine Humez, Lester Binder, Rakez Kayed, Bruno Lefebvre, Eliette Bonnefoy, Luc Buée, Marie Christine Galas

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The accumulation of DNA and RNA oxidative damage is observed in cortical and hippocampal neurons from Alzheimer's disease (AD) brains at early stages of pathology. We recently reported that Tau is a key nuclear player in the protection of neuronal nucleic acid integrity in vivo under physiological conditions and hyperthermia, a strong inducer of oxidative stress. In a mouse model of tauopathy (THY-Tau22), we demonstrate that hyperthermia selectively induces nucleic acid oxidative damage and nucleic acid strand breaks in the nucleus and cytoplasm of hippocampal neurons that display early Tau phosphorylation but no Tau fibrils. Nucleic acid-damaged neurons were exclusively immunoreactive for prefibrillar Tau oligomers. A similar association between prefibrillar Tau oligomers and nucleic acid oxidative damage was observed in AD brains. Pretreatment with Methylene Blue (MB), a Tau aggregation inhibitor and a redox cycler, reduced hyperthermia-induced Tau oligomerization as well as nucleic acid damage. This study clearly highlights the existence of an early and critical time frame for hyperthermia-induced Tau oligomerization, which most likely occurs through increased oxidative stress, and nucleic acid vulnerability during the progression of Tau pathology. These results suggest that at early stages of AD, Tau oligomerization triggers the loss of the nucleic acid protective function of monomeric Tau. This study highlights the existence of a short therapeutic window in which to prevent the formation of pathological forms of Tau and their harmful consequences on nucleic acid integrity during the progression of Tau pathology.

Original languageEnglish (US)
Pages (from-to)540-551
Number of pages12
JournalNeurobiology of Disease
Volume82
DOIs
StatePublished - Oct 1 2015

Fingerprint

Nucleic Acids
Neurons
Alzheimer Disease
Induced Hyperthermia
Pathology
Oxidative Stress
Fever
Tauopathies
Methylene Blue
Brain
Oxidation-Reduction
Cytoplasm
Phosphorylation
RNA
DNA

Keywords

  • Alzheimer
  • DNA damage
  • Hyperthermia
  • Methylene Blue
  • Oxidative stress
  • RNA damage
  • Tau
  • Tau oligomers

ASJC Scopus subject areas

  • Neurology

Cite this

Violet, M., Chauderlier, A., Delattre, L., Tardivel, M., Chouala, M. S., Sultan, A., ... Galas, M. C. (2015). Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. Neurobiology of Disease, 82, 540-551. https://doi.org/10.1016/j.nbd.2015.09.003

Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. / Violet, Marie; Chauderlier, Alban; Delattre, Lucie; Tardivel, Meryem; Chouala, Meliza Sendid; Sultan, Audrey; Marciniak, Elodie; Humez, Sandrine; Binder, Lester; Kayed, Rakez; Lefebvre, Bruno; Bonnefoy, Eliette; Buée, Luc; Galas, Marie Christine.

In: Neurobiology of Disease, Vol. 82, 01.10.2015, p. 540-551.

Research output: Contribution to journalArticle

Violet, M, Chauderlier, A, Delattre, L, Tardivel, M, Chouala, MS, Sultan, A, Marciniak, E, Humez, S, Binder, L, Kayed, R, Lefebvre, B, Bonnefoy, E, Buée, L & Galas, MC 2015, 'Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo', Neurobiology of Disease, vol. 82, pp. 540-551. https://doi.org/10.1016/j.nbd.2015.09.003
Violet, Marie ; Chauderlier, Alban ; Delattre, Lucie ; Tardivel, Meryem ; Chouala, Meliza Sendid ; Sultan, Audrey ; Marciniak, Elodie ; Humez, Sandrine ; Binder, Lester ; Kayed, Rakez ; Lefebvre, Bruno ; Bonnefoy, Eliette ; Buée, Luc ; Galas, Marie Christine. / Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. In: Neurobiology of Disease. 2015 ; Vol. 82. pp. 540-551.
@article{efcfd00468e1460ebae8de2918558ebe,
title = "Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo",
abstract = "The accumulation of DNA and RNA oxidative damage is observed in cortical and hippocampal neurons from Alzheimer's disease (AD) brains at early stages of pathology. We recently reported that Tau is a key nuclear player in the protection of neuronal nucleic acid integrity in vivo under physiological conditions and hyperthermia, a strong inducer of oxidative stress. In a mouse model of tauopathy (THY-Tau22), we demonstrate that hyperthermia selectively induces nucleic acid oxidative damage and nucleic acid strand breaks in the nucleus and cytoplasm of hippocampal neurons that display early Tau phosphorylation but no Tau fibrils. Nucleic acid-damaged neurons were exclusively immunoreactive for prefibrillar Tau oligomers. A similar association between prefibrillar Tau oligomers and nucleic acid oxidative damage was observed in AD brains. Pretreatment with Methylene Blue (MB), a Tau aggregation inhibitor and a redox cycler, reduced hyperthermia-induced Tau oligomerization as well as nucleic acid damage. This study clearly highlights the existence of an early and critical time frame for hyperthermia-induced Tau oligomerization, which most likely occurs through increased oxidative stress, and nucleic acid vulnerability during the progression of Tau pathology. These results suggest that at early stages of AD, Tau oligomerization triggers the loss of the nucleic acid protective function of monomeric Tau. This study highlights the existence of a short therapeutic window in which to prevent the formation of pathological forms of Tau and their harmful consequences on nucleic acid integrity during the progression of Tau pathology.",
keywords = "Alzheimer, DNA damage, Hyperthermia, Methylene Blue, Oxidative stress, RNA damage, Tau, Tau oligomers",
author = "Marie Violet and Alban Chauderlier and Lucie Delattre and Meryem Tardivel and Chouala, {Meliza Sendid} and Audrey Sultan and Elodie Marciniak and Sandrine Humez and Lester Binder and Rakez Kayed and Bruno Lefebvre and Eliette Bonnefoy and Luc Bu{\'e}e and Galas, {Marie Christine}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.nbd.2015.09.003",
language = "English (US)",
volume = "82",
pages = "540--551",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo

AU - Violet, Marie

AU - Chauderlier, Alban

AU - Delattre, Lucie

AU - Tardivel, Meryem

AU - Chouala, Meliza Sendid

AU - Sultan, Audrey

AU - Marciniak, Elodie

AU - Humez, Sandrine

AU - Binder, Lester

AU - Kayed, Rakez

AU - Lefebvre, Bruno

AU - Bonnefoy, Eliette

AU - Buée, Luc

AU - Galas, Marie Christine

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The accumulation of DNA and RNA oxidative damage is observed in cortical and hippocampal neurons from Alzheimer's disease (AD) brains at early stages of pathology. We recently reported that Tau is a key nuclear player in the protection of neuronal nucleic acid integrity in vivo under physiological conditions and hyperthermia, a strong inducer of oxidative stress. In a mouse model of tauopathy (THY-Tau22), we demonstrate that hyperthermia selectively induces nucleic acid oxidative damage and nucleic acid strand breaks in the nucleus and cytoplasm of hippocampal neurons that display early Tau phosphorylation but no Tau fibrils. Nucleic acid-damaged neurons were exclusively immunoreactive for prefibrillar Tau oligomers. A similar association between prefibrillar Tau oligomers and nucleic acid oxidative damage was observed in AD brains. Pretreatment with Methylene Blue (MB), a Tau aggregation inhibitor and a redox cycler, reduced hyperthermia-induced Tau oligomerization as well as nucleic acid damage. This study clearly highlights the existence of an early and critical time frame for hyperthermia-induced Tau oligomerization, which most likely occurs through increased oxidative stress, and nucleic acid vulnerability during the progression of Tau pathology. These results suggest that at early stages of AD, Tau oligomerization triggers the loss of the nucleic acid protective function of monomeric Tau. This study highlights the existence of a short therapeutic window in which to prevent the formation of pathological forms of Tau and their harmful consequences on nucleic acid integrity during the progression of Tau pathology.

AB - The accumulation of DNA and RNA oxidative damage is observed in cortical and hippocampal neurons from Alzheimer's disease (AD) brains at early stages of pathology. We recently reported that Tau is a key nuclear player in the protection of neuronal nucleic acid integrity in vivo under physiological conditions and hyperthermia, a strong inducer of oxidative stress. In a mouse model of tauopathy (THY-Tau22), we demonstrate that hyperthermia selectively induces nucleic acid oxidative damage and nucleic acid strand breaks in the nucleus and cytoplasm of hippocampal neurons that display early Tau phosphorylation but no Tau fibrils. Nucleic acid-damaged neurons were exclusively immunoreactive for prefibrillar Tau oligomers. A similar association between prefibrillar Tau oligomers and nucleic acid oxidative damage was observed in AD brains. Pretreatment with Methylene Blue (MB), a Tau aggregation inhibitor and a redox cycler, reduced hyperthermia-induced Tau oligomerization as well as nucleic acid damage. This study clearly highlights the existence of an early and critical time frame for hyperthermia-induced Tau oligomerization, which most likely occurs through increased oxidative stress, and nucleic acid vulnerability during the progression of Tau pathology. These results suggest that at early stages of AD, Tau oligomerization triggers the loss of the nucleic acid protective function of monomeric Tau. This study highlights the existence of a short therapeutic window in which to prevent the formation of pathological forms of Tau and their harmful consequences on nucleic acid integrity during the progression of Tau pathology.

KW - Alzheimer

KW - DNA damage

KW - Hyperthermia

KW - Methylene Blue

KW - Oxidative stress

KW - RNA damage

KW - Tau

KW - Tau oligomers

UR - http://www.scopus.com/inward/record.url?scp=84947021770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947021770&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2015.09.003

DO - 10.1016/j.nbd.2015.09.003

M3 - Article

VL - 82

SP - 540

EP - 551

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -